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Streszczenie
Wstęp. Przewlekłe zapalenie trzustki jest łagodnym, zapalnym procesem chorobowym
odpowiedzialnym za powiększenie głowy trzustki, znaczne dolegliwości bólowe,
postepującą utratę wagi ciała i istotne pogorszenie jakości życia (QoL).
Materiał i metody. W pracy przedstawiono kliniczne doświadczenie związane z
wykonywaniem resekcji głowy trzustki z zachowaniem dwunastnicy i oszczędzaniem
miąższu trzustki (duodenum and organ-preserving pancreatic head resection –
DOPPHR) u 180 chorych w okresie 12 lat. Oceniano jakość życia (QoL) w okresie
pooperacyjnym z wykorzystaniem metody EORTC QoL-C 30.
Wyniki. Średni czas operacji wynosił 165 minut. Nie obserwowano zgonów w okresie
okołooperacyjnym. Z powodu powikłań pooperacyjnych (krwawienie z zespolenia i
niedrożność jelit) zaistniała konieczność reperacji u trzech chorych. Średni czas pobytu
w szpitalu wynosił 7-12 dni. Średni czas obserwacji pooperacyjnej wynosił 6,5 lat (0,5-
12 lat). 12 chorych zmarło w odległym okresie po operacji, tzw. późna śmiertelność
wyniosła 6,7%.
Uzyskano poprawę jakości życia u 89% operowanych. 150 chorych było
bezobjawowych, a u 18 chorych objawy chorobowe były miernie nasilone. W okresie
pooperacyjnym obserwowano średni przyrost wagi ciała około 13,2 kg (zakres od 4-30
kg). Pooperacyjna czynność endokrynna trzustki była porównywalna do czynności
przedoperacyjnej.
Wnioski. 12-letni okres doświadczeń w wykonywaniu operacji DOPPHR wykazał, że
technika ta jest bezpieczna i skuteczna w chirurgicznym leczeniu powikłanego
przewlekłego zapalenia trzustki.
Słowa kluczowe: przewlekłe zapalenie trzustki, leczenie chirurgiczne, oszczędzanie
dwunastnicy i trzustki, długoterminowa obserwacja pooperacyjna, jakość życia
Summary
Introduction. Chronic pancreatitis (CP), a benign, inflammatory process, can cause
enlargement of the pancreatic head, which is accompanied by severe pain and weight
loss, and often leads to a significant reduction in the quality of life (QoL).
Material and methods. Our clinical experience relates to the results attained with
duodenum and organ-preserving pancreatic head resection (DOPPHR) in 180 patients
during a 12-year period. The QoL is assessed during the follow-up period by using
EORTC QoL-C30.
Results. The mean operating time was l65 min. Three reoperations were required in
consequence of anastomosis bleeding and small bowel obstruction, but no mortality was
noted in the postoperative period. Duration of hospitalization ranged between 7 and 12
days. The mean follow-up time was 6.5 years (range 0.5-12.0). The late mortality rate
was 6.7% (12 patients). The QoL improved in 89% of the cases. 150 of the patients
became complaint-free, while 18 had moderate symptoms, and the weight increased by
a median of 13.2 kg (range 4-30). The preoperative and postoperative endocrine
functions remained in almost the same stage as preoperatively.
Conclusions. This 12-year experience clearly demonstrates that this DOPPHR
technique is a safe and effective procedure, which should be preferred in the surgical
treatment of the complications of CP.
Key words: chronic pancreatitis, surgery, duodenum and organ preservation, long-term
follow up, quality of life
Introduction
Chronic pancreatitis (CP) is a benign, inflammatory disease of the pancreas, which can
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Chronic pancreatitis (CP) is a benign, inflammatory disease of the pancreas, which can
cause enlargement of the pancreatic head with severe pain and weight loss and often
reduces the quality of life (QoL) significantly. The enlarged inflamed head of the pancreas
can lead to complications such as obstruction of the pancreatic duct, common bile duct
stenosis and duodenal compression. These are all indications for surgical treatment:
resection of the pancreatic head. The surgical treatment consists in different types of
pancreatic head resection (1): pylorus-preserving pancreaticoduodenectomy (PPPD)
(2), Beger’s duodenum-preserving pancreatic head resection (DPPHR) (3), and Frey’s
longitudinal pancreaticojejunostomy combined with local pancreatic head excision (LPJ-
LPHE) (4). PPPD and Beger’s DPPHR involve total and subtotal resection of the
pancreatic head, respectively, which can be regarded as too invasive in cases of benign
disease and do not adhere to the modern organ-preserving concept. Twelve years ago,
therefore, a new duodenum and organ-preserving pancreatic head resection (DOPPHR)
method was developed, which is essentially suitable for this purpose (5-8). Preliminary
clinical results achieved with this operation, together with follow-up findings, were
published recently (9-11). The present article reports on late follow-up (mean, 6.5 years
[range 0.5-12.0]) results attained with our DOPPHR on 180 patients, including QoL
parameters.
Material and methods
Since 1999, we have performed a DOPPHR to treat inflammatory tumours of
the pancreatic head (median diameter 68 mm [range 45-132 mm], as assessed
by helical CT scan) in 180 patients (133 men and 47 women; mean age: 48.4 yr.
[range 27-68]). The preoperative morbidity involved frequent, sometimes severe
abdominal pain, a significant loss in body weight in all patients, jaundice in 10 patients,
duodenal obstruction in 16 patients and latent (LDM) and insulin-dependent diabetes
mellitus (IDDM) in 33 and 29 patients, respectively. The mean interval between the
appearance of the symptoms and the surgical intervention was 7.9 ± 2.6 yr. The
aetiology was connected with chronic alcohol ingestion in 157 patients (87 per
cent) and with biliary stone disease in 18 patients (10 per cent), and was unknown
in 5 patients. The diagnosis of CP was confirmed by ERCP, MRCP, sonography and
the CT scan. ERCP reveals that the diameter of the main pancreatic duct varied between
2 and 8 mm. In 10 icteric patients and in 21 patients without jaundice, the common bile
duct was stenotic, due to inflammatory tumour compression with prestenotic dilatation,
combined with high levels of alkaline phosphatase (range 956-1345 U/L). The CT scan
demonstrated parenchyma calcification in 95 patients; 27 patients exhibited pseudocystic
cavities, and 4 patients portal hypertension (tab. 1).
Table 1. Clinical characteristics of 160 patients undergoing DOPPHR*.
Age (yr, mean, range) 48.4 (27-68)
Sex ratio (male/female) 133/47
Aetiology (per cent)
Alcohol ingestion
Biliary stone
Unknown
157 (87)
18 (10)
5 (3)
Duodenal obstruction (per cent) 16 (8.9)
Head enlargement (per cent)
Pseudocystic cavity
180 (100)
27 (15)
Parenchymal calcification (per cent) 95 (52.7)
Bile duct obstruction (per cent)
Jaundice
31 (17.2)
10 (5.6)
Portal hypertension (per cent) 4 (2.2)
Pain intensity (per cent)
Weak
Moderate
Severe
10 (5.6)
135 (75)
35 (19.4)
Preoperative weight (kg, mean, range) 50.2 (42-66)
Diabetes mellitus (per cent)
None 118 (65.5)
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None
Latent
Insulin-dependent
118 (65.5)
33 (18.4)
29 (16.1)
*Numbers of patients are shown, percentages given in parentheses.
Pancreatic functions were checked by means of stool elastase determination by a
sandwich ELISA method (Pancreatic Elastase1®, ScheBo Biotech, Giessen, Germany)
(12). The glucose tolerance test was applied to check the endocrine function. Blood
glucose levels were measured by means of glucose oxidase assay 0, 30, 60, 90 and 120
min following administration of 75 g oral glucose.
Prophylactic antibiotic (ceftriaxone) was administered preoperatively, and in the early
postoperative period all of the patients received standard supportive treatment,
consisting of total parenteral nutrition for 4 days, a proton pump antagonist
(pantoprazole), suppression of TNF synthesis (pentoxifylline) and octreotide medication
(13). The oral nutrition was started on postoperative day 5.
Operative procedure
The surgical procedure involved a wide local resection of the inflammatory tumour in the
region of the pancreatic head, and decompression of the organ and the intrapancreatic
segment of the common bile duct if the prepapillary duct had become stenotic. The
operative procedure started with the Kocher manoeuvre, partial dissection of the
gastrocolic ligament for mobilization, and exploration of the head of the pancreas,
without division and cutting of the pancreas over the portal vein. An intraoperative frozen
section was performed for all patients; none of them revealed signs of malignancy. The
following step of the operative procedure was ligation of the pancreaticoduodenal artery
and the veins directed to the duodenum and to the superior mesenteric vein. The
enlarged pancreatic head was excised in almost its entirety, leaving behind a bridge of
pancreatic tissue about 10 mm wide, while a rim of pancreas (5 to 10 mm) remained
beside the duodenum and on the upper margin of the pancreatic head. This wide excision
gives a possibility for drainage of the pancreatic juice from the distal pancreas and for
opening of the prepapillary obstructed common bile duct in icteric patients and in those
with a stenotic common bile duct. The prestenotic dilated common bile duct was opened
with an incision about 8-10 mm long, and the opened duct wall was sutured to the
surrounding pancreatic tissue with interrupted Vicryl® 3/0 sutures. After careful
haemostasis of the operative region, reconstruction, with drainage of the secretion from
the remaining pancreas into the intestinal tract, took place through a jejunal Roux-en-Y
loop, with the application of one-layer interrupted Vicryl® 2/0 sutures (7) (fig. 1.)
Fig. 1. The operation consists in a wide local resection of the inflammatory tumor in the
region of the pancreatic head, without division and cutting of the pancreas over the portal
vein. Reconstruction, with drainage of the secretion from the remaining pancreas into the
intestinal tract, takes place through a jejunal Roux-en-Y loop. In icteric cases,
prepapillary bile duct anastomosis is also performed with the jejunal loop.
Quality of life
The QoL and pain score before and after surgery were assessed by using the European
Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life
Questionnaire (QLQ-C30) (14). The EORTC QLQ-C30 has been re-evaluated and
demonstrated to be a valid and reliable with tool which to measure the QoL in patients
with benign diseases such as CPl5. It comprises items relating to the physical status, the
working ability, the emotional, cognitive and social functioning, and an overall QoL scale.
Pain intensity was estimated by means of a pain-scoring system including a visual
analogue scale, the frequency of pain attacks, the use of analgesic medication, and the
duration of the inability to work. The overall pain score was given by the sum of the
individual part-scores divided by 4. This questionnaire was prospectively assessed at
two time points during the study: before the surgical procedure, and in the follow-up
period, a mean of 6.5 years after the operation.
Statistical analysis
The details of the statistical analysis are presented in the manuscript as follows: The
results on the parametric data are expressed as means ± standard deviation, and
nonparametric data as medians. Statistical significance was estimated by using Student’s
t test or the Wilcoxon rank test, as appropriate. The level of significance was set at P <
0·050.
Results
In 180 patients, the DOPPHR procedure was performed after the development of an
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In 180 patients, the DOPPHR procedure was performed after the development of an
inflammatory tumour of the pancreatic head. The intraoperative parameters and post
surgical events are listed in table 2. The mean operation time was 165 min (range 120-
230 min) and there was no indication for blood transfusion during the operations. In the
postoperative period, three reoperations were required in consequence of anastomosis
bleeding (2 patients) and small bowel obstruction (1 patient). Another 3 patients with
anastomosis bleeding were treated conservatively, and 1 patient had pneumonia, but
there was no septic complication, anastomosis insufficiency or other problem; the
morbidity was therefore 3.9 per cent. There was no mortality in the postoperative
period. In the 31 icteric and common bile duct stenotic patients (17.2 per cent), the liver
functions normalized following the operation (serum bilirubin < 22 μmol/L, and alkaline
phosphatase 232 ± 92 U/L; as compared with the preoperative data, the reduction was
significant [P = 0·048]). The duration of hospitalization ranged between 7 and 12 days,
by a mean of 8.5 days. The histological examinations confirmed fibrosis and calcification
in 85 and 95 patients, respectively.
Table 2. Intraoperative parameters and early post surgical outcome after DOPPHR in
160 CP patients*.
Operative time (min, mean, range) 165 (120-230)
Intrapancreatic bile duct anastomosis
(per cent)
31 (17.2)
Intraoperative blood transfusion 31 (17.2)
Intraoperative blood transfusion 0
Relaparotomy (per cent)
Anastomosis bleeding
Small bowel obstruction
3 (1.7)
2
1
Nonsurgical morbidity (per cent)
Bleeding treated conservatively
Pneumonia
4 (2.2)
3
1
Pancreatic fistula 0
Wound infection 0
Anastomosis leakage 0
Abscesses or fluid collection 0
Overall morbidity (per cent) 7 (3.9)
Mortality (per cent) 0 (0)
Post surgical hospital stay (day, mean, range) 8.5 (7-12)
*Numbers of patients are shown, percentages given in parentheses.
The mean follow-up period was 6.5 years (range 0.5-12.0). Twelve patients were lost
to follow-up (6.7 per cent). Complete follow-up data on 168 patients were included in
the evaluation; the follow-up rate was therefore 93.3 per cent. 150 patients became
complaint-free (83.3 per cent), while 18 patients displayed moderate symptoms; and the
body weight increased by a mean of 13.2 kg (range 4-30) (P = 0·041). In the long-term
period, 9 patients underwent operation again: a bilio-digestive bypass was indicated in
consequence of bile duct stenosis that developed in 7 patients, and distal pancreatic
resection and splenectomy were performed in another 2 patients. In the follow-up
period, a further 13 patients were admitted to the clinic with an acute episode of
pancreatitis; all of them were treated conservatively. Readmission was therefore
necessary in 22 of the 168 cases (13.1 per cent). The late mortality was 6.7 per cent (12
patients); the reasons were myocardial infarction in 5 patients, a stroke in 2 patients,
gastrointestinal tumour (oesophagus, stomach, and large-bowel) in 4 patients and an
accident (1 patient) (tab. 3).
Table 3. Follow-up after DOPPHR (n = 149 patients)*.
Follow-up period (yr, mean, range) 6.5 (0.5-12.0)
Complete follow-up (per cent) 168 (93.3)
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Late mortality (pts, per cent) 12 (6.7)
Pain (per cent) 18 (10)
Pain intensity (per cent)
None
Moderate
150 (89)
18 (10)
Readmission (per cent) 22 (13.1)
Late reoperation (per cent)
Bilio-digestive bypass
Distal pancreatic resection
9 (5)
7
2
Acute pancreatitis (per cent) 13 (7.2)
Late morbidity (per cent) 22 (12.2)
Body weight increase (kg, mean, range) 13.2 (4-30)
Diabetes mellitus (per cent)
None
Latent
Insulin-dependent
97 (57.7)
22 (13)
49 (29.3)
*Numbers of patients are shown, percentages given in parentheses.
The stool elastase level increased slightly, but not significantly (from 124.3 ± 33 to 132 ±
39 μg/g; NS). The preoperative and postoperative endocrine functions were in almost
the same stage: 97 patients were normoglycemic, 22 had LDM and 39 had IDDM, in 10
patients LDM becoming IDDM (6.6 per cent).
Both before the operation and during the follow-up, the patients were asked to complete
the EORTC QLQ-C30 questionnaire. The completed questionnaires before and after
the surgical treatment were evaluated in 134 patients (74 per cent). The other patients
were excluded from the evaluation because of incomplete data or a lack of cooperation,
or the data on the patients were not available. The questionnaire was compared at two
time points: (1) before the operation and (2) at a mean follow-up of 6.5 years (range
0.5-12) after surgery. The median pain score decreased by 90 per cent (P = 0·001). No
patient subsequently suffered a frequent pain attack and only 10 per cent of the patients
mentioned moderate pain occasionally (tab. 4). During the follow-up, the median global
QoL improved by 100 per cent. Apart from the cognitive functioning, the physical status,
working ability, emotional and social functioning all improved significantly (P = 0·046).
The results of the symptom scales are presented in table 5.
Table 4. Preoperative and follow-up pain scores (n = 134).
Criterion
Preoperative score
(median [range])
Follow-up score
(median [range])
P*
Pain visual
analogue scale
82 (55-100) 10 (0-15)  
Frequency of pain
attack
75 (50-100) 12.5 (0-15)  
Pain medication 22 (20-100) 0 (0-100)  
Inability to work 76 (75-100) 4 (0-100)  
Pain score 65 (50-100) 5.6 (0-37.5) 0·001
*Preoperative values were compared with follow-up values by the Wilcoxon rank sum
test (P < 0.001).
Table 5. EORTC QLQ-C30 preoperative and follow-up functioning scale scores (n =
134).
Functioning
scale
Preoperative score
(median [range])
Follow-up score (median
[range])
P*
Physical status 60 (20-100) 70 (20-100) 0·049
Working ability 49 (0-100) 71 (0-100) 0·048
0·196
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Cognitive 50 (40-80) 66 (40-100)
0·196
NS
Emotional 25 (0-75) 66.7 (40-100) 0·045
Social 16 (0-66.7) 65.7 (0-100) 0·040
Overall quality
of life
28.5 (14.3-57.1) 57.5 (33.3-100) 0·046
*Preoperative values were compared with follow-up values by the Wilcoxon rank sum
test (P < 0.05); NS: not significant.
Discussion
Patients with CP who present with inflammatory pancreatic head enlargement commonly
require pancreatic head resection because of the development of local complications (eg.
stenosis of the common bile duct and/or main pancreatic duct, duodenal obstruction) and
persistent, uncontrolled pain. The aims of surgical therapy, therefore, are pain relief, the
management of CP-associated complications of adjacent organs, and the possibility for
preservation of the endocrine and exocrine functions with reasonably low morbidity
rates, and finally, it is important to improve the patients’ overall QoL and physical status,
and also to provide for their social and occupational rehabilitation (16). For several
decades, classical Whipple’s pancreatoduodenectomy (PD) and PPPD were applied as
standard surgical procedures for pancreatic head complications in CP, but the long-term
results and QoL improvement following these operations were disappointing, with high
rates of late morbidity and mortality and with a high incidence (up to 48 per cent) of
postoperative DM (17). Although two recently published articles have described better
results (18, 19), it is generally accepted that these operations, involving the removal of
healthy adjacent organs, do not seem to be warranted in this benign disease unless there
is a strong suspicion of cancer (20).
In 1972, Beger performed a more effective organ-preserving procedure, DPPHR, which
preserves the entire duodenum and reduces the incidence of postsurgical DM (3). In
1987, Frey et al. described a modification of this procedure, in which resection and
drainage were combined into a single procedure (LPJ-LPHE) (4). In both operations,
the resection or excision of the pancreatic head is limited, but achieves reliable pain relief
and allows definitive management of the pancreatitis-associated complications of the
adjacent organs and an improved QoL (21-23). Since 1995, some important
randomized studies have compared the different types of pancreatic head resection.
Büchler demonstrated better pain relief and a better pancreatic function when DPPHR
was compared with PPPD (24). Almost the same results were reported by Klempa,
who compared DPPHR and PD: the degree of pain relief was the same, but the
recovery was quicker and the pancreatic function became better after Beger’s operation
(25). Möbius et al. reached the same results but in a prospective non-randomized study
(26). Two randomized studies were also performed to analyze the pancreatic function
and QoL after Frey’s LPJ-LPHE or DPPHR: the level of pain relief was identical, but
the QoL was better following Frey’s operation (27, 28). Recently published articles
based on the long-term follow-up of randomized trials have concluded that there was no
difference between the two operations as regards the mortality, QoL, pain, or exocrine
or endocrine insufficiency and also indicated that these operations are advantageous for
the treatment of CP. The decision as to which procedure to choose should be based on
the surgeon’s experience (29-31). The recent systematic review and meta-analysis by
Diener et al. came to the same conclusion: DPPHR and PD seem to be equally effective
in terms of the postoperative pain relief, the overall morbidity, and the incidence of
postoperative endocrine insufficiency. However, the presented findings suggested the
superiority of DPPHR in the treatment of CP with regard to several peri- and
postoperative outcome parameters and the QoL (32).
In approximately 30 per cent of patients with CP, the disease is primarily located in the
head of the pancreas, which is considered to act as the pacemaker to trigger the
inflammatory process; resection of this inflammatory mass must be regarded as pivotal in
the surgical intervention (1). Basically, CP is a benign, but sometimes progressive
disease, and the duodenum and organ-preserving concept must therefore be accepted.
The resection process removes only sufficient of the pancreatic head to guarantee the
flow of both ductal systems (the bile and the pancreas) so as to preserve the
physiological gastroduodenal and the endocrine functions. In the past six years, a number
of publications have proved that the concept for DOPPHR is correct (7-10, 29-30, 33).
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The results of two recent prospective randomized control trials which compared
DOPPHR with either PPPD or DPPHR demonstrated that DOPPHR is superior to both
PPPD and DPPHR not only in the operation data and morbidity, but also in the QoL
achieved (34-35).
The present article is concerned with our late follow-up (on average 6.5 years [range
0.5-12.0]) results attained with DOPPHR on 180 patients. These data demonstrated
that DOPPHR is a safe operative procedure, as confirmed by the low morbidity (3.9 per
cent) and the absence of mortality among the patients in the postoperative period. An
additional important feature is the fact that the mean duration of hospitalization was only
8.5 days. In the mean follow-up period of 6.5 years, 150 patients became complaint-
free (89 per cent), while 18 displayed only moderate symptoms and the body weight
increased significantly by a mean of 13.2 kg (range 4-30). Readmission was required for
22 of the 168 patients (13 per cent) as a consequence of relaparotomy (a bilio-digestive
bypass or distal pancreatic resection) or conservatively treated pancreatitis. The late
mortality was 6.7 per cent: 12 patients died. The postoperative endocrine function
remained in almost the same stage as preoperatively.
The degree of pain relief and the extent of improvement in the QoL after surgery for CP
in the patients were assessed by using the EORTC QLQ-C30. The completed
questionnaires before and after the surgical treatment were evaluated in 134 patients
(79.7 per cent). The median pain score was found to have decreased by 90 per cent (P
= 0·001). No patient subsequently suffered from frequent pain attacks and only 10 per
cent of them mentioned occasional moderate pain. During the follow-up, the median
global QoL improved by 100 per cent. Apart from the cognitive functioning, the physical
status, working ability, and emotional and social functioning all improved significantly (P
= 0·046).
The early and long-term results of DOPPHR operations indicate the advantage of this
procedure in a wide scale of indications, involving different pathologic processes, e.g. a
subacute or chronic inflammation mass with a pseudocyst, ductal stenosis or obstruction
(of the common bile duct or the pancreatic duct) caused by CP.
In conclusion, the results of our clinical study clearly demonstrate that DOPPHR is a
safe and effective procedure for resolving the complications following the inflammatory
alterations of CP, and suggest that this operation furnishes effective early and late long-
term results, mainly with regard to the QoL. However, in the future, a multicentre,
randomized controlled trial comparing resection procedures with organ-preserving
technique will be expected to provide more data on the best surgical opinion for patients
with CP36.
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